This article does a clear and concise job of summarising a complex and interesting study looking at novel biomarkers of early Parkinson's Disease. The article explains scientific concepts (like the interpretation of an ROC-AUC value) and the technology in an accessible way. It mentions potential caveats, such as the need for more work to validate the test, in particular in relation to other conditions.